BIGG

New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice

Lindner, Andreas K; Lejon, Veerle; Chappuis, François; Seixas, Jorge; Kazumba, Leon; Barrett, Michael P; Mwamba, Erick; Erphas, Olema; Akl, Elie A; Villanueva, Gemma; Bergman, Hanna; Simarro, Pere; Ebeja, Augustin Kadima; Priotto, Gerardo; Franco, Jose Ramon.

Lancet infect. dis; 20 (2), 2020

Human African trypanosomiasis caused by Trypanosoma brucei gambiense is a parasitic infection that usually progresses to coma and death unless treated. WHO has updated its guidelines for the treatment of this infection on the basis of independent literature reviews and using the Grading of Recommendation...

Maladie du sommeil/traitement médicamenteux, Trypanosoma brucei gambiense, Pentamidine/administration et posologie, Nifurtimox/administration et posologie, Nitroimidazoles/administration et posologie, Liquide cérébrospinal/parasitologie, Association de médicaments, Trypanocides/administration et posologie, Eflornithine/administration et posologie, Maladie du sommeil/parasitologie

Texte intégral

Guía para el diagnóstico y el tratamiento de la enfermedad de Chagas

This document is a valuable working tool for anyone who works in the health networks of Latin American countries. It describes the most recent basic and fundamental guidelines for the diagnosis and treatment of American trypanosomiasis (Chagas disease) based on the evidence published to date, and is now ...